<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The anti-Epstein-Barr Virus (EBV) myristoylated-<z:chebi fb="7" ids="16670">peptide</z:chebi> (M.W </plain></SENT>
<SENT sid="1" pm="."><plain>916.2Da) is a natural product isolated from Heliothis virescens insect larval hemolymph (blood) that essentially has no cytotoxicity against human foreskin fibroblast cells </plain></SENT>
<SENT sid="2" pm="."><plain>A (3 methyl only) version (M.W </plain></SENT>
<SENT sid="3" pm="."><plain>902.2 Da) of the structure was synthesized and tested for in vitro anti-EBV activity and cytotoxicity </plain></SENT>
<SENT sid="4" pm="."><plain>The N-terminal end is lipophilic and used to get the compound across the cell membrane </plain></SENT>
<SENT sid="5" pm="."><plain>The C-terminal end with its ring-shaped structures is likely used to inhibit DNA synthesis </plain></SENT>
<SENT sid="6" pm="."><plain>The synthetic compound inhibited DNA synthesis/replication of EBV in Akata cells (B-lymphocyte from Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patient) in in vitro tissue culture </plain></SENT>
<SENT sid="7" pm="."><plain>A DNA hybridization assay for anti-EBV activity using the Akata B-cell and two cytotoxicity assays using human foreskin fibroblast cells were done with the synthetic <z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Effective concentration (EC90) at 20 microM inhibited <z:mp ids='MP_0001799'>viral</z:mp> replication by 90% </plain></SENT>
<SENT sid="9" pm="."><plain>The EBV, known as Human Herpesvirus-4 (HHV-4) of the Herpesviridae family, has been described as a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-promoting <z:chebi fb="0" ids="4705">double-stranded DNA</z:chebi> virus that may also be involved in <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>There are no <z:chebi fb="1" ids="36044">antiviral drugs</z:chebi> in clinical use for diseases caused by the EBV </plain></SENT>
</text></document>